Le Lézard
Classified in: Health, Business
Subjects: PDT, CXP

Transpara AI Breast Care - Global Expansion planned for 2022.


NIJMEGEN, Netherlands, Jan. 18, 2022 /PRNewswire/ -- Following the success of the world's leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide, ScreenPoint Medical, the company that developed Transpara, is to launch a major expansion.

 

Screenpoint Medical Logo

 

The FDA and CE marked Transpara AI software reads mammograms to find cancers faster and at an earlier stage. 2022 will see a larger global team and further research and development resulting in an expansion of ScreenPoint's product portfolio.  ScreenPoint will bring out new features faster to meet the growing global demand.

ScreenPoint Chief Executive, Professor Nico Karssemeijer said Transpara stands out with its validation in multiple studies across the globe, demonstrating the significant benefits of using deep learning artificial intelligence in mammography and tomosynthesis.

"Given the increasing demand for the product and with the pressure on radiologists and the increasing incidence of breast cancer worldwide, it is vital we make optimal  use of this new technology to find cancers faster and earlier, especially the most aggressive ones, so that survival rates improve," he said.

"With the growing shortage of specialist breast radiologists worldwide and the negative impact of Covid related delays in screening, we have to do all we can to provide the best possible care to women at risk for breast cancer."

Transpara is now leading the way for prospective studies, peer reviewed publications and ongoing clinical studies in Europe and around the world.

Transpara is now being used in two prospective studies in Sweden and another in Spain with a second study also being proposed. In addition, in Denmark Transpara is being used in a major health service screening programme.

Professor Karssemeijer's comments have been echoed by a number of leading experts in breast care during an expert panel discussion during EUSOBI online.

Dr Sylvia Heywang Köbrunner of Munich said, "I think this is the future and we must adapt to the future. We cannot avoid it. It is so important to miss as few cancers as possible"

Dr Marina Benito of Hospital Universitario Reina Sofia, Spain agreed.

"In one of our studies, we have demonstrated that AI can help to identify up to 70% of the screening studies as very likely normal, reducing workload - without decreasing sensitivity and it also reduces recalls."

Dr Roger Yang of University Radiology Group, USA said, "We're seeing more and more adoption of digital breast tomosynthesis. DBT adds a lot more complexity, especially with comparisons to priors here in the States. Also, radiologists have to integrate and interface with software reporting systems.   We're looking for ways to make screening more efficient." 

For more information, please visit:

www.screenpoint-medical.com

SOURCE ScreenPoint Medical


These press releases may also interest you

at 07:05
Mannatech, Incorporated , a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended December 31, 2023. Fourth Quarter Highlights Fourth...

at 07:02
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA's...

at 07:00
Giyani Metals Corp. ("Giyani" or the "Company"), developer of the K.Hill battery-grade manganese project in Botswana ("K.Hill"), is pleased to announce that the TSX Venture Exchange ("TSXV") has conditionally approved the US$16 million facility...

at 07:00
Carbon Streaming Corporation (Cboe CA: NETZ) ("Carbon Streaming" or the "Company") today reported its financial results for the fiscal year ended December 31, 2023. All figures are expressed in United States dollars, unless otherwise indicated. The...

at 07:00
Telesat , one of the world's largest and most innovative satellite operators, today announced its financial results for the three-month and one-year periods ended December 31, 2023. All amounts are in Canadian dollars and reported under International...

at 07:00
Aya Gold & Silver Inc. ("Aya" or the "Corporation") is pleased to announce financial and operational results for the fourth quarter and year ended December 31, 2023. All amounts are in US dollars, unless otherwise stated. Annual Highlights...



News published on and distributed by: